Reactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine Uniflu
type: MedicalStudy
description: Reactogenicity, Safety and Immunogenicity of an Recombinant Universal Influenza Vaccine Uniflu in Healthy Volunteers From 18 to 60 Years Old
status: UNKNOWN
study design: INTERVENTIONAL
phase: PHASE1
start date: 2018-06-02
end date: 2018-12-31
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT03789539
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: VA Pharma Limited Liability Company
study subject: Safety Issues
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: UNKNOWN
keywords: Safety Issues

AI Analytics
type: Organization